KLK3 and prostate carcinoma: EMPD patient had a higher incidence of prostate cancer with PSA levels above 4.0 ng/mL, and interestingly, PSA levels are usually higher than 90 ng/mL in EMPD prostate cancer patients (80%, 4/5).